chartexchange

VRDN
Viridian Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 19, 2026 3:59:58 PM EST
31.44USD+4.382%(+1.32)4,018,084
Pre-marketNov 19, 2026 8:55:30 AM EST
30.45USD+1.096%(+0.33)
After-hoursNov 19, 2026 4:16:30 PM EST
31.30USD-0.445%(-0.14)
31.43Bid31.46Ask0.03Spread

VRDN Financials

In Q3 FY 2026 (ended ), Viridian Therapeutics, Inc. Common Stock (VRDN) reported revenue of $25.75M, net income of −$101.21M, operating cash flow of −$92.77M, and assets of $1.03B (filed ).

Loading business breakdowns…